The investigation of expression of CD95, CD44V6 in breast cancer and lymph node micrometastasis
10.3760/cma.j.issn.1006-9801.2009.04.011
- VernacularTitle:CD95、CD44V6与乳腺癌淋巴结微小转移的关系
- Author:
Lixia WANG
;
Li LI
;
Suhong LI
;
Ruifang SUN
;
Wei BAI
;
Quanhong WANG
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Lymphatic metastasis;
Fas/FasL;
CD44V6;
Immunohistochemistry
- From:
Cancer Research and Clinic
2009;21(4):248-250
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the relationship and clinicopathologic significance between the expression of CD95,CD44V6 and metastasis of axillary lymph node in breast cancer.Methods Immunohistochemistry was used to detect the expression of CD95 and CD44V6 in 101 cases of breast cancer, in which, 40 cases without metastasis in axillary lymph node were detected MCK expression by IHC. The results were analyzed statistically. Results 9 cases of breast cancer with lymph node micrometastasis were observed by IHC in 40 cases without metastasis in axillary lymph node by microscope. The expression of CD95, CD44V6 in lymph node metastasis group was similar as in lymph node micrometastasis group. There was significant difference of CD95 expression between those with lymph node metastasis and those without. The positive rate of CD95 and the high expression of CD44V6 in the cases that the tumor size was over 2 cm were significandy higher than in the cases that the tumor size was less than 2 cm (P<0.05). Conclusion Detection of the expression of CD95, CD44V6 in breast cancer may be helpful to predict the lymph node micrometastasis and provide more dependable evidence for judging prognosis and selecting treatment prescription clinically.
